Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-07

Clinical Trial Update: A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

View source ↗

Summary

A registry study update on sipuleucel-T therapy in men with advanced prostate cancer, with completed status and results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • sipuleucel-T (sipuleucel-T)

Snippet

Sponsor: Dendreon | Conditions: Advanced Prostate Cancer, Prostatic Neoplasms | Status: COMPLETED | Results posted: 2019-06-07